Will someone refresh my poor memory on share price
Will someone refresh my poor memory on share price valuation:
What is the biotech industry standard for multiples of projected revenue which the share price typically is at? I seem to recall distant past discussions of 4x by legitimate posters on the other site.
So just for the sake of argument if CTIX has roughly 150m outstanding shares and the share price is $180 pps, then the company should be valued at roughly $27b, correct? The would mean that the market or the BP partner will be expecting the drugs to net around $6-7b in revenues a year? Am I thinking about this correctly? That seems high, so what am I missing?
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
FlexCare: A New Era in Vehicle Protection Stellantis has introduced FlexCare as the new name for its vehicle service contracts and protection offerings. This innovative program replaces the former Mopar Vehicle Protection (MVP), bringing a familiar level of expert factory service and a diverse array of tailored vehicle protection products to customers. What is FlexCare?...
Continue Reading
Clean Juice Launches a Unique Promotion Clean Juice, the leading brand in organic juice bars, is dedicated to making nutritious choices more accessible to everyone. Their latest promotion allows customers to purchase a signature cold-pressed juice for just 20 cents with a $25 purchase. This initiative is designed to encourage a healthier lifestyle as we enter a new year...
Continue Reading
Economic Insights on Tariff Rollbacks Recent actions by President Trump to roll back specific tariffs aim to address the soaring prices affecting consumers, an approach labeled as a "remarkable admission" by notable economist Justin Wolfers. This move suggests that the administration recognizes the inflationary impact of its previous trade policies. Understanding Tariff...
Continue Reading
Introduction to New Credit Facilities Flow Traders Ltd. (Euronext: FLOW) has recently secured significant financial backing through a new credit facility, which includes a $200 million private credit and a $75 million revolving credit facility. This strategic move aims to enhance the firm's trading capital and fortify its global operations. Details of the Credit...
Continue Reading
New Perspectives on Community Development Finance In a compelling recent release, David Fukuzawa, Nancy O. Andrews, and Rebecca Steinitz introduced a fresh approach to community development finance. Their article, titled "A New Blueprint for Financing Community Development," published by Stanford Social Innovation Review, emphasizes the need for innovative financing...
Continue Reading
